Assuntos
Dismenorreia/etiologia , Dismenorreia/cirurgia , Baço/anormalidades , Baço/cirurgia , Adulto , Anormalidades Congênitas/diagnóstico , Dismenorreia/diagnóstico , Feminino , Seguimentos , Humanos , Achados Incidentais , Pelve , Índice de Gravidade de Doença , Esplenectomia/métodos , Tomografia Computadorizada por Raios X/métodos , Resultado do Tratamento , Ultrassonografia Doppler/métodosRESUMO
OBJECTIVE: To evaluate MR accuracy for staging endometrial carcinoma with different FIGO staging systems. METHODS: Between August 2006 and July 2010, 95 women underwent surgery for endometrial carcinoma.In each patient, endometrial carcinoma was staged with magnetic resonance (MR) findings based on the old FIGO staging system and then repeated according to the new FIGO staging system for comparisons.Histopathologic findings were used as a golden standard to compare the sensitivity, specificity, accuracy, positive predictive value and negative predictive value. RESULTS: The accuracy of MRI in the staging of endometrial carcinoma stageI, II and III with the old FIGO staging system were 83.2%, 86.3% and 92.6% versus 88.4%, 96.8% and 91.6% respectively with the new FIGO staging criteria.According the old FIGO staging system, the sensitivity of stage IA, IB and IC were 51.8%, 76.5% and 50.0% and the specificity 85.3% , 55.7% and 95.4% respectively; the sensitivity of stage IIA and IIB were merely 12.5% and 20.0% and the specificity 97.7% and 100.0%.With the new FIGO staging criteria, the above indices were 97.1%, 55.6%, 57.7%, 95.3%, 40.0% and 100.0% respectively. CONCLUSION: With new FIGO staging system versus the old one, the accuracy of MR imaging in the preoperative staging of endometrial carcinoma increases.
Assuntos
Neoplasias do Endométrio/patologia , Imageamento por Ressonância Magnética/normas , Estadiamento de Neoplasias/normas , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Imageamento por Ressonância Magnética/métodos , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Estudos Retrospectivos , Sensibilidade e Especificidade , Adulto JovemRESUMO
Malignant tumors in the tonsils are usually primary. Metastases to the tonsils are extremely rare, with nearly one hundred cases reported. Herein we present an unusual case of palatine tonsillar metastasis of non-small cell lung cancer during chemotherapy. The patient was a 39-year-old man who was diagnosed as non-small lung cancer with IIIA4 staging and poor differentiated histology. After two cycles of vinorelbine and cisplatin based chemotherapy, a big mass was developed in the right palatine tonsil which was pathologically confirmed as the metastasis from the lung. There was no hemorrhage and complains except moderate foreign body sensations. No cervical lymphadenopathy and distal metastases to other organs such as brain and liver was found. Because of poor overall performance status, no radiotherapy was given. The disease progressed after docetaxel treatment. To the best of our knowledge, this is the first case with palatine tonsillar metastasis from non-small lung cancer during induction chemotherapy.